HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Lipp Selected Research

Cations

1/2020Domain zipping and unzipping modulates TRPM4's properties in human cardiac conduction disease.
9/2015A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Lipp Research Topics

Disease

5Cardiac Arrhythmias (Arrythmia)
12/2017 - 03/2012
4Fibrosis (Cirrhosis)
12/2021 - 06/2012
3Inflammation (Inflammations)
12/2021 - 01/2021
3Heart Diseases (Heart Disease)
01/2020 - 07/2013
3Hypertrophy
09/2015 - 08/2012
2Cardiomegaly (Heart Hypertrophy)
01/2021 - 09/2015
2Polymorphic catecholergic ventricular tachycardia
12/2017 - 03/2012
2Atrial Fibrillation
08/2012 - 08/2010
1Fatty Liver
01/2023
1Vascular System Injuries
12/2021
1Atherosclerosis
01/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1Ventricular Tachycardia
12/2017
1Cardiovascular Diseases (Cardiovascular Disease)
12/2017
1Thromboembolism
10/2016
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
07/2013
1Sickle Cell Anemia (Hemoglobin S Disease)
05/2013
1Thalassemia
05/2013
1Insulinoma
08/2012
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
06/2012
1Malignant Hyperthermia
03/2012
1Alzheimer Disease (Alzheimer's Disease)
01/2012
1Amyloid Plaque
01/2012
1Drug-Related Side Effects and Adverse Reactions
01/2012
1Neoplasms (Cancer)
10/2008
1Melanoma (Melanoma, Malignant)
10/2008
1Testicular Neoplasms (Testicular Cancer)
10/2008
1Infections
07/2007
1Heart Failure
09/2006
1Vascular Remodeling
09/2006
1Thrombosis (Thrombus)
12/2004

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2006
2InflammasomesIBA
12/2021 - 01/2021
2NLR ProteinsIBA
12/2021 - 01/2021
2CationsIBA
01/2020 - 09/2015
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
12/2017 - 03/2012
2AldosteroneIBA
10/2016 - 08/2012
2Glucose (Dextrose)FDA LinkGeneric
01/2015 - 08/2012
2CalciumIBA
06/2012 - 12/2004
1SteroidsIBA
01/2023
1Triglycerides (Triacylglycerol)IBA
12/2021
1ApolipoproteinsIBA
12/2021
1Lipoproteins (Lipoprotein)IBA
12/2021
1AlarminsIBA
01/2021
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2021
1kaempferolIBA
12/2017
1Anti-Arrhythmia AgentsIBA
12/2017
1Hormones (Hormone)IBA
01/2016
1ReninIBA
09/2015
1Atrial Natriuretic Factor (ANF)IBA
09/2015
1Fatty Acids (Saturated Fatty Acids)IBA
01/2015
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2015
1LipidsIBA
01/2015
1Protein Isoforms (Isoforms)IBA
07/2013
1NADPH Oxidases (NAD(P)H oxidase)IBA
07/2013
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2013
1PhosphofructokinasesIBA
05/2013
1Mitochondrial Proteins (Mitochondrial Protein)IBA
08/2012
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
08/2012
1Protein Kinases (Protein Kinase)IBA
08/2012
1Transcription Factors (Transcription Factor)IBA
08/2012
1GTP Phosphohydrolases (GTPases)IBA
08/2012
1TamoxifenFDA LinkGeneric
06/2012
1Calmodulin (Calcium-Dependent Activator Protein)IBA
06/2012
1Dantrolene (Dantrium)FDA LinkGeneric
03/2012
1CalsequestrinIBA
03/2012
1Cardiovascular AgentsIBA
01/2012
1Amyloid (Amyloid Fibrils)IBA
01/2012
1GangliosidesIBA
01/2012
1Amyloid beta-PeptidesIBA
01/2012
1Monomeric GTP-Binding ProteinsIBA
08/2010
1HLA-A*02:01 antigenIBA
10/2008
1AntigensIBA
10/2008
1Neoplasm Antigens (Tumor Antigens)IBA
10/2008
1EpitopesIBA
10/2008
1Protein Kinase CIBA
07/2007
1Prostaglandins EIBA
12/2004
1Dinoprostone (PGE2)FDA Link
12/2004

Therapy/Procedure

2Therapeutics
03/2012 - 01/2012
1Ligation
12/2021